VYNE
NASDAQ · Pharmaceuticals
Vyne Therapeutics Inc
$0.65
+0.00 (+0.00%)
Open$0.65
Previous Close$0.65
Day High$0.66
Day Low$0.65
52W High$1.96
52W Low$0.28
Volume—
Avg Volume135.2K
Market Cap21.21M
P/E Ratio—
EPS$-0.50
SectorPharmaceuticals
Analyst Ratings
Strong Buy
8 analysts
Price Target
+2,898.5% upside
Current
$0.65
$0.65
Target
$19.49
$19.49
$14.75
$19.49 avg
$26.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 444.0K | 419.3K | 2.72M |
| Net Income | -20,672,061 | -17,568,323 | 604.8K |
| Profit Margin | -4,646.1% | -4,413.8% | 22.3% |
| EBITDA | -23,205,991 | -20,817,461 | 831.2K |
| Free Cash Flow | — | — | 485.0K |
| Rev Growth | +5.9% | +5.9% | -5.6% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |